FDA Inspection 1329486 — Phoenix RX LLC
The FDA completed an inspection of Phoenix RX LLC on Jun 29, 2026 in Hatboro, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 29, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hatboro, PA (United States)